Schiffer CA - Search Results

1

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Rubin EH, Andersen JW, Berg DT, Schiffer CA, Mayer RJ, Stone RM. Rubin EH, et al. Among authors: schiffer ca. J Clin Oncol. 1992 Jun;10(6):948-53. doi: 10.1200/JCO.1992.10.6.948. J Clin Oncol. 1992. PMID: 1588374 Clinical Trial.

2

Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B.

Mayer RJ, Davis RB, Schiffer CA, Berg DT, Sarno E, Frei E 3rd. Mayer RJ, et al. Among authors: schiffer ca. Leukemia. 1992;6 Suppl 2:66-7. Leukemia. 1992. PMID: 1578945 Clinical Trial. No abstract available.

3

Low dose 5-azacytidine is ineffective for remission induction in patients with acute myeloid leukemia.

Lee EJ, Hogge DE, Gallagher R, Schiffer CA. Lee EJ, et al. Among authors: schiffer ca. Leukemia. 1990 Dec;4(12):835-8. Leukemia. 1990. PMID: 1700839

4

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.

Ellison RR, Mick R, Cuttner J, Schiffer CA, Silver RT, Henderson ES, Woliver T, Royston I, Davey FR, Glicksman AS, et al. Ellison RR, et al. Among authors: schiffer ca. J Clin Oncol. 1991 Nov;9(11):2002-15. doi: 10.1200/JCO.1991.9.11.2002. J Clin Oncol. 1991. PMID: 1941059 Clinical Trial.

5

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, et al. Cheson BD, et al. Among authors: schiffer ca. J Clin Oncol. 1990 May;8(5):813-9. doi: 10.1200/JCO.1990.8.5.813. J Clin Oncol. 1990. PMID: 2185339 Review.

6

Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia.

Paciucci PA, Davis RB, Holland JF, Martelo O, Schiffer CA. Paciucci PA, et al. Among authors: schiffer ca. Am J Clin Oncol. 1990 Dec;13(6):516-9. doi: 10.1097/00000421-199012000-00013. Am J Clin Oncol. 1990. PMID: 2239806 Clinical Trial.

7

Treatment of relapsed and refractory acute myeloid leukemia with diaziquone and mitoxantrone: a CALGB phase I study.

Amrein PC, Davis RB, Mayer RJ, Schiffer CA. Amrein PC, et al. Among authors: schiffer ca. Am J Hematol. 1990 Oct;35(2):80-3. doi: 10.1002/ajh.2830350203. Am J Hematol. 1990. PMID: 2399909

8

Morphologic and cytochemical characteristics of acute promyelocytic leukemia.

Davey FR, Davis RB, MacCallum JM, Nelson DA, Mayer RJ, Ball ED, Griffin JD, Schiffer CA, Bloomfield CD. Davey FR, et al. Among authors: schiffer ca. Am J Hematol. 1989 Apr;30(4):221-7. doi: 10.1002/ajh.2830300406. Am J Hematol. 1989. PMID: 2539013

9

A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings.

Karesh JW, Goldman EJ, Reck K, Kelman SE, Lee EJ, Schiffer CA. Karesh JW, et al. Among authors: schiffer ca. J Clin Oncol. 1989 Oct;7(10):1528-32. doi: 10.1200/JCO.1989.7.10.1528. J Clin Oncol. 1989. PMID: 2778482

10

Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.

Griffin JD, Davis R, Nelson DA, Davey FR, Mayer RJ, Schiffer C, McIntyre OR, Bloomfield CD. Griffin JD, et al. Blood. 1986 Dec;68(6):1232-41. Blood. 1986. PMID: 2946331 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters